Literature DB >> 35411531

Anticoagulant Prescriptions Provided in US Ambulatory Practice, 2014 to 2016.

Tali Azenkot1, Brittany Chatterton2,3, Eleanor Bimla Schwarz4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35411531      PMCID： PMC9550935          DOI： 10.1007/s11606-022-07536-y

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   6.473


× No keyword cloud information.
  5 in total

Review 1.  2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons.

Authors:  Craig T January; L Samuel Wann; Hugh Calkins; Lin Y Chen; Joaquin E Cigarroa; Joseph C Cleveland; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Karen L Furie; Paul A Heidenreich; Katherine T Murray; Julie B Shea; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2019-01-28       Impact factor: 29.690

2.  Race/Ethnicity and Sex-Related Differences in Direct Oral Anticoagulant Initiation in Newly Diagnosed Atrial Fibrillation: A Retrospective Study of Medicare Data.

Authors:  Utibe R Essien; Jared W Magnani; Nemin Chen; Walid F Gellad; Michael J Fine; Inmaculada Hernandez
Journal:  J Natl Med Assoc       Date:  2020-02-06       Impact factor: 1.798

3.  Trends and Variation in Oral Anticoagulant Choice in Patients with Atrial Fibrillation, 2010-2017.

Authors:  Junya Zhu; G Caleb Alexander; Saman Nazarian; Jodi B Segal; Albert W Wu
Journal:  Pharmacotherapy       Date:  2018-07-26       Impact factor: 4.705

4.  Factors Associated With the Choice of Oral Anticoagulant Class in the Older Patients: An Observational Study.

Authors:  Arnaud Pagès; Rémi Sabatier; Brigitte Sallerin
Journal:  J Cardiovasc Pharmacol Ther       Date:  2020-04-08       Impact factor: 2.457

5.  Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report.

Authors:  Scott M Stevens; Scott C Woller; Lisa Baumann Kreuziger; Henri Bounameaux; Kevin Doerschug; Geert-Jan Geersing; Menno V Huisman; Clive Kearon; Christopher S King; Andrew J Knighton; Erica Lake; Susan Murin; Janine R E Vintch; Philip S Wells; Lisa K Moores
Journal:  Chest       Date:  2021-08-02       Impact factor: 9.410
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.